Using peripheral blood progenitor cells (PBPC) for transplantation in pediatric patients: a state-of-the-art review (Q34165168)

31 July 2017

1 reference

title

Using peripheral blood progenitor cells (PBPC) for transplantation in pediatric patients: a state-of-the-art review (English)

1 reference

31 July 2017

Díaz MA

1

1 reference

31 July 2017

Kanold J

2

1 reference

31 July 2017

Vicent MG

3

1 reference

31 July 2017

Halle P

4

1 reference

31 July 2017

Madero L

5

1 reference

31 July 2017

Deméocq F

6

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 December 2000

1 reference

Bone Marrow Transplantation

31 July 2017

published in

1 reference

31 July 2017

volume

26

1 reference

31 July 2017

issue

12

1 reference

31 July 2017

page(s)

1291-1298

1 reference

Peripheral blood progenitor cell collection by large-volume leukapheresis in low-weight children

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

Feasibility of peripheral blood stem cell (PBSC) and peripheral blood mononuclear cell (PBMNC) separation in children with a body weight below 20 KG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

Peripheral-blood stem-cell collections after paclitaxel, cyclophosphamide, and recombinant human granulocyte colony-stimulating factor in patients with breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

Administration of recombinant human granulocyte colony-stimulating factor to normal donors: results of the Spanish National Donor Registry. Spanish Group of Allo-PBT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

Peripheral blood stem cell mobilization and apheresis: analysis of adverse events in 94 normal donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

Peripheral blood stem cell autografts for the treatment of childhood cancer: a review of the Japanese experience. Japanese Cooperative Study Group of PBSCT (JCSG/PBSCT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

Large-volume leukapheresis procedure for peripheral blood progenitor cell collection in children weighing 15 kg or less: efficacy and safety evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

Autotransplants with peripheral blood stem cells and clinical results obtained in children: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

Double-conditioning regimens consisting of thiotepa, melphalan and busulfan with stem cell rescue for the treatment of pediatric solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

Analysis of platelet recovery after autologous transplantation with G-CSF mobilized CD34+ cells purified from leukapheresis products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

Feasibility of a PB CD34+ cell transplantation procedure using standard leukapheresis products in very small children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

Selection and transplantation of autologous hematopoietic CD34+ cells for patients with multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

Gene-marking to trace origin of relapse after autologous bone-marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

Molecular monitoring of tumor cell contamination in leukapheresis products from stage IV neuroblastoma patients before and after positive CD34 selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

Immunological and molecular detection of tumor contamination in leukapheresis products from children with disseminated neuroblastoma: implication for evaluation of tumor cell depletion after CD34 selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas: hematologic recovery and costs. A randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

Prognostic factors in metastatic neuroblastoma in patients over 1 year of age treated with high-dose chemotherapy and stem cell transplantation: a multivariate analysis in 218 patients treated in a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

Stem cell factor leads to reduced blood processing during apheresis or the use of whole blood aliquots to support dose-intensive chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

Cytokine-mobilized allogeneic peripheral blood stem cell transplants in children result in rapid engraftment and a high incidence of chronic GVHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

Allogeneic PBPC transplantation in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

Clinical collection and use of peripheral blood stem cells in pediatric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

7 January 2021

Allogeneic peripheral blood stem cell transplant in children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

7 January 2021

Kinetics of hematopoietic progenitor cell release induced by G-CSF-alone in children with solid tumors and leukemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

7 January 2021

Safe and efficient peripheral blood stem cell collection in the smallest of children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

7 January 2021

Pediatric large volume peripheral blood progenitor cell collections from patients under 25 kg: a primer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

7 January 2021

Collection and use of peripheral blood stem cells in young children with refractory solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

7 January 2021

Use of G-CSF alone to mobilize peripheral blood stem cells for collection from children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

7 January 2021

Collection and transplantation of peripheral blood progenitor cells mobilized by G-CSF alone in children with malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

7 January 2021

Mobilization and harvesting of peripheral blood stem cells: randomized evaluations of different doses of filgrastim

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

7 January 2021

Recommendations on the use of colony-stimulating factors in children: conclusions of a European panel

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

7 January 2021

Peripheral blood progenitor cell (PBPC) collection by large-volume leukapheresis from pediatric donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

7 January 2021

Use of minors as bone marrow donors: current attitude and management. A survey of 56 pediatric transplantation centers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

7 January 2021

Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedures

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

7 January 2021

Transient neutropenia in normal donors after G-CSF mobilization and stem cell apheresis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

7 January 2021

Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

7 January 2021

Apparent reactivation of a red cell alloantibody in a healthy individual after G-CSF administration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

7 January 2021

Positive selection and transplantation of peripheral CD34+ progenitor cells: feasibility and purging efficacy in pediatric patients with neuroblastoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

7 January 2021

Analysis of engraftment kinetics in pediatric patients undergoing autologous PBPC transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

7 January 2021

Efficacy of autologous peripheral blood stem cell (PBSC) harvest and engraftment after ablative chemotherapy in pediatric patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

7 January 2021

Single institution experience with mobilization, harvesting, and reinfusion of peripheral blood stem cells in children with a solid tumor or leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

7 January 2021

Non-tunneled catheters for the collection and transplantation of peripheral blood stem cells in children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

7 January 2021

Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

7 January 2021

Evaluation of the Fresenius cell separator AS 104 for harvesting peripheral blood stem cells in pediatric patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

7 January 2021

Peripheral blood progenitor cell collections in children with low platelet counts are safe

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

7 January 2021

Autologous CD34-selected blood progenitor cell transplants for patients with advanced multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

7 January 2021

CD34+ cell immunoselection from G-CSF-alone-primed peripheral blood in children with low body mass

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

7 January 2021

Clinically applicable bulk isolation of blood CD34+ cells for autografting in children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

7 January 2021

Allogeneic peripheral blood stem cell transplantation in children with hematologic malignancies from HLA-matched siblings

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

7 January 2021

Long-term results of CD34(+) cell transplantation in children with neuroblastoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

7 January 2021

Factors that influence collection and engraftment of autologous peripheral-blood stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

7 January 2021

Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

7 January 2021

Subsets of CD34+ cells and rapid hematopoietic recovery after peripheral-blood stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

7 January 2021

Progenitor cell subsets and engraftment kinetics in children undergoing autologous peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

7 January 2021

Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

7 January 2021

Peripheral blood stem cell apheresis in normal donors: feasibility and yield of second collections

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

7 January 2021

Allogeneic peripheral blood stem cell transplantation for haematological malignancies--an analysis of kinetics of engraftment and GVHD risk

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702725

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1702725

1 reference

Dimensions Publication ID

31 July 2017

1053397148

0 references

1 reference